Design, cytotoxic and fluorescent properties of novel N-phosphorylalkyl substituted E, E-3,5-bis(arylidene)piperid-4-ones

A series of E, E- N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones 7a– k was prepared via the condensation of aromatic aldehydes with ω-aminophosphonates 5a– c and 6a, b bearing piperidone or a protected piperidone moiety, respectively. The synthetic routes to the starting aminophosphonates 5a–...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry Vol. 44; no. 5; pp. 2135 - 2144
Main Authors: Makarov, Michael V., Rybalkina, Ekaterina Yu, Röschenthaler, Gerd-Volker, Short, Kurt W., Timofeeva, Tatiana V., Odinets, Irina L.
Format: Journal Article
Language:English
Published: France Elsevier Masson SAS 01-05-2009
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract A series of E, E- N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones 7a– k was prepared via the condensation of aromatic aldehydes with ω-aminophosphonates 5a– c and 6a, b bearing piperidone or a protected piperidone moiety, respectively. The synthetic routes to the starting aminophosphonates 5a– c and 6a, b varied depending on the number of methylene groups in the alkylene chain and comprised the Kabachnik–Fields reaction ( n = 1), the aza-Michael reaction ( n = 2) or alkylation of 4-piperidone hydrochloride with diethyl ω-bromoalkylphosphonates under phase transfer catalysis conditions ( n = 3,4). Phosphoryl substituted 3,5-bis(arylidene)piperid-4-ones 7b, c, e, f, h, i, k bearing both nitro groups and fluorine atoms in the para-position of the arene rings possess cytotoxicity toward human carcinoma cell lines CaOv3, Scov3, PC3 and A549 in the low micromolar range while their analogues having para-dimethylamino groups had IC 50 values greater than 50 μM. In contrast, only Me 2N-substituted phosphonates 7g, j ( n = 3 and 4) and the salts of Me 2N-substituted phosphonic acids 10c, f ( n = 2 and 3) display fluorescence. Condensation of ω-aminophosphonates bearing piperidone or a protected piperidone moiety with aromatic aldehydes provides a convenient approach to E, E- N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones possessing dark cytotoxicity towards human carcinoma cell lines CaOv3, Scov3, PC3 and A549 in the low micromolar range in the case of electron withdrawing substituents in the benzene rings and fluorescence properties for those having electron-donating groups. ▪
AbstractList A series of E,E-N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones 7a-k was prepared via the condensation of aromatic aldehydes with omega-aminophosphonates 5a-c and 6a,b bearing piperidone or a protected piperidone moiety, respectively. The synthetic routes to the starting aminophosphonates 5a-c and 6a,b varied depending on the number of methylene groups in the alkylene chain and comprised the Kabachnik-Fields reaction (n=1), the aza-Michael reaction (n=2) or alkylation of 4-piperidone hydrochloride with diethyl omega-bromoalkylphosphonates under phase transfer catalysis conditions (n=3,4). Phosphoryl substituted 3,5-bis(arylidene)piperid-4-ones 7b,c,e,f,h,i,k bearing both nitro groups and fluorine atoms in the para-position of the arene rings possess cytotoxicity toward human carcinoma cell lines CaOv3, Scov3, PC3 and A549 in the low micromolar range while their analogues having para-dimethylamino groups had IC(50) values greater than 50 microM. In contrast, only Me(2)N-substituted phosphonates 7g,j (n=3 and 4) and the salts of Me(2)N-substituted phosphonic acids 10c,f (n=2 and 3) display fluorescence.
A series of E, E- N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones 7a– k was prepared via the condensation of aromatic aldehydes with ω-aminophosphonates 5a– c and 6a, b bearing piperidone or a protected piperidone moiety, respectively. The synthetic routes to the starting aminophosphonates 5a– c and 6a, b varied depending on the number of methylene groups in the alkylene chain and comprised the Kabachnik–Fields reaction ( n = 1), the aza-Michael reaction ( n = 2) or alkylation of 4-piperidone hydrochloride with diethyl ω-bromoalkylphosphonates under phase transfer catalysis conditions ( n = 3,4). Phosphoryl substituted 3,5-bis(arylidene)piperid-4-ones 7b, c, e, f, h, i, k bearing both nitro groups and fluorine atoms in the para-position of the arene rings possess cytotoxicity toward human carcinoma cell lines CaOv3, Scov3, PC3 and A549 in the low micromolar range while their analogues having para-dimethylamino groups had IC 50 values greater than 50 μM. In contrast, only Me 2N-substituted phosphonates 7g, j ( n = 3 and 4) and the salts of Me 2N-substituted phosphonic acids 10c, f ( n = 2 and 3) display fluorescence. Condensation of ω-aminophosphonates bearing piperidone or a protected piperidone moiety with aromatic aldehydes provides a convenient approach to E, E- N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones possessing dark cytotoxicity towards human carcinoma cell lines CaOv3, Scov3, PC3 and A549 in the low micromolar range in the case of electron withdrawing substituents in the benzene rings and fluorescence properties for those having electron-donating groups. ▪
Author Odinets, Irina L.
Rybalkina, Ekaterina Yu
Timofeeva, Tatiana V.
Short, Kurt W.
Makarov, Michael V.
Röschenthaler, Gerd-Volker
Author_xml – sequence: 1
  givenname: Michael V.
  surname: Makarov
  fullname: Makarov, Michael V.
  organization: A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilova str. 28, 119991 Moscow, Russia
– sequence: 2
  givenname: Ekaterina Yu
  surname: Rybalkina
  fullname: Rybalkina, Ekaterina Yu
  organization: Institute of Carcinogenesis, Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe sh. 24, 115478 Moscow, Russia
– sequence: 3
  givenname: Gerd-Volker
  surname: Röschenthaler
  fullname: Röschenthaler, Gerd-Volker
  organization: Institute for Inorganic and Physical Chemistry, University of Bremen, Leobener Strasse, D-28334 Bremen, Germany
– sequence: 4
  givenname: Kurt W.
  surname: Short
  fullname: Short, Kurt W.
  organization: New Mexico Highlands University, Las Vegas, NM 87701, USA
– sequence: 5
  givenname: Tatiana V.
  surname: Timofeeva
  fullname: Timofeeva, Tatiana V.
  organization: New Mexico Highlands University, Las Vegas, NM 87701, USA
– sequence: 6
  givenname: Irina L.
  surname: Odinets
  fullname: Odinets, Irina L.
  email: odinets@ineos.ac.ru
  organization: A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilova str. 28, 119991 Moscow, Russia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19046794$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1rGzEQhkVJaJyk_6AUHVuwnNHXZnUphMT5AJNemvOyK802cterRZJN_e8j40BvOQwDw_vOvPOck5MxjEjIVw4LDry6Wi9wvUH7uhAAdRktgJtPZMavq5pJodUJmYEQkmkh1Rk5T2kNALoC-EzOuAFVXRs1I_s7TP7POKd2n0MO_7yl7ehoP2xDxGRxzHSKYcKYPSYaejqGHQ70mU2vIZWK-6Ed_u4HmrZdyj5vMzq6nNMlk3PNOp--t0XiHY74Y_Jlj3dMsfJJuiSnfTsk_PLeL8jL_fL37SNb_Xp4ur1ZMSsryEw54J1uZVXVVY-gsVamdlx01gppTdu1ErURSjsFreDcGF0bNJYrW1SykxdEHffaGFKK2DdT9JuSquHQHEg26-ZIsjmQPEwLyWL7drRN226D7r_pHV0R_DwKsITfeYxNsh5Hi85HtLlxwX984Q20UYlj
CitedBy_id crossref_primary_10_1007_s00044_014_1262_z
crossref_primary_10_1016_j_bmcl_2014_09_074
crossref_primary_10_1134_S1070428023100111
crossref_primary_10_1007_s00044_016_1726_4
crossref_primary_10_1016_j_tet_2012_10_059
crossref_primary_10_1007_s11172_014_0752_y
crossref_primary_10_1002_jhet_2143
crossref_primary_10_1016_j_molstruc_2013_03_053
crossref_primary_10_1016_j_molstruc_2011_06_020
crossref_primary_10_1021_jm200353f
crossref_primary_10_1107_S2053229619014360
crossref_primary_10_1016_j_molstruc_2012_12_034
crossref_primary_10_2174_2211352517666190820143735
crossref_primary_10_1080_10426507_2013_797415
crossref_primary_10_1007_s11172_014_0569_8
crossref_primary_10_1016_j_cdc_2018_04_008
crossref_primary_10_1016_j_bmcl_2009_09_069
crossref_primary_10_1080_10426507_2010_520281
crossref_primary_10_1080_10426507_2012_717147
crossref_primary_10_1002_ardp_201100352
crossref_primary_10_1002_hlca_201000005
crossref_primary_10_1016_j_tetlet_2010_07_072
crossref_primary_10_1080_10426507_2012_736101
crossref_primary_10_1002_hc_21082
crossref_primary_10_1007_s40242_013_2525_9
crossref_primary_10_1111_cbdd_12254
crossref_primary_10_1007_s00044_013_0624_2
crossref_primary_10_1007_s11172_017_1707_x
crossref_primary_10_1016_j_tet_2011_10_085
crossref_primary_10_1080_10426507_2019_1633319
crossref_primary_10_1016_j_ejmech_2009_11_041
crossref_primary_10_1002_jhet_1944
crossref_primary_10_1021_acs_energyfuels_7b00708
crossref_primary_10_1007_s00044_013_0557_9
crossref_primary_10_1107_S0108270113006185
crossref_primary_10_1080_10426507_2010_514308
crossref_primary_10_1139_cjc_2017_0099
crossref_primary_10_1016_j_ejmech_2010_09_058
crossref_primary_10_1016_j_mencom_2015_05_026
crossref_primary_10_1016_j_molstruc_2023_137097
ContentType Journal Article
Copyright 2008 Elsevier Masson SAS
Copyright_xml – notice: 2008 Elsevier Masson SAS
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/j.ejmech.2008.10.019
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1768-3254
EndPage 2144
ExternalDocumentID 10_1016_j_ejmech_2008_10_019
19046794
S0223523408005357
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JN
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
M2Y
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCB
SCC
SDF
SDG
SES
SEW
SOC
SPC
SPCBC
SPT
SSK
SSP
SSU
SSZ
T5K
WUQ
~G-
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ID FETCH-LOGICAL-c360t-4d01b5a36686fe05e8498d12bcc23c9aba3e59245d40a21199589e9c14cd123b3
ISSN 0223-5234
IngestDate Thu Sep 26 18:17:05 EDT 2024
Sat Sep 28 07:54:57 EDT 2024
Fri Feb 23 02:33:50 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Aminophosphonates
Synthesis
Structure–cytotoxicity–fluorescence relationship
N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones
N-phosphorylalkylene-piperid-4-ones
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c360t-4d01b5a36686fe05e8498d12bcc23c9aba3e59245d40a21199589e9c14cd123b3
PMID 19046794
PageCount 10
ParticipantIDs crossref_primary_10_1016_j_ejmech_2008_10_019
pubmed_primary_19046794
elsevier_sciencedirect_doi_10_1016_j_ejmech_2008_10_019
PublicationCentury 2000
PublicationDate 2009-05-01
PublicationDateYYYYMMDD 2009-05-01
PublicationDate_xml – month: 05
  year: 2009
  text: 2009-05-01
  day: 01
PublicationDecade 2000
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle European journal of medicinal chemistry
PublicationTitleAlternate Eur J Med Chem
PublicationYear 2009
Publisher Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
References (bib29) 2000
Al-Omar, Youssef, El-Sherbeny, Awadalla, El-Subbagh (bib8) 2005; 338
Matveeva, Petrovskii, Odinets (bib31) 2008; 49
Dimmock, Jha, Zello, Sharma, Shrivastav, Selvakumar, Allen, Santos, Balzarini, De Clercq, Manavathu, Stables (bib4) 2003; 18
Sørensen, Blæhr, Christensen, Høyer, Hjarnaa, Björkling (bib28) 2003; 11
Szakacs, Annerau, Lababidi, Shankavaram, Arciello, Bussey, Reinhold, Guo, Kruh, Reimers, Weinstein, Gottesman (bib24) 2004; 6
Pati, Das, Quail, Kawase, Sakagami, Dimmock (bib5) 2008; 43
Youssef, El-Sherbeny, El-Shafle, Farag, Al-Deeb, Awadalla (bib13) 2004; 337
Das, Alcorn, Shrivastav, Sharma, De Clercq, Balzarini, Dimmock (bib6) 2007; 42
Dimmock, Kandepu, Nazarali, Kowalchuk, Motaganahalli, Quail, Mykytiuk, Audette, Prasad, Perjési, Allen, Santos, Szydlowski, De Clercq, Balzarini (bib12) 1999; 42
Nesterov, Timofeeva, Sarkisov, Leyderman, Lee, Antipin (bib23) 2003; C59
Gufford, Shaw, Dallas, Koovakkat, Lee, Liang, Light, McCarrick, Whitlow, Ye, Morrissey (bib14) 1999; 42
Collins, Stark (bib26) 1971; 246
Maciejewski, Steer (bib32) 1986; 35
Hewitt, Newland (bib33) 1977; 30
Dimmock, Padmanilayam, Zello, Nienaber, Allen, Santos, De Clercq, Balzarini, Manavathu, Stables (bib15) 2003; 38
Dimmock, Arora, Wonko, Hamon, Quail, Jia, Warrington, Fang, Lee (bib10) 1990; 6
Makarov, Odinets, Lyssenko, Rybalkina, Kosilkin, Antipin, Timofeeva (bib30) 2008; 45
Kumar, Narain, Misra (bib19) 2001; 12
Bonhote, Moser, Humphry-Baker, Vlachopoulus, Zakeeruddin, Walder, Grätzel (bib34) 1999; 121
Asaoka, Oka, Yoshida, Sasaki, Nishizuka (bib27) 1992; 89
Dimmock, Arora, Chen, Allen, Kao (bib2) 1994; 12
Jobin, Bradham, Russi, Juma, Narula, Brenner, Sartor (bib18) 1999; 163
Arnold, Bourswaux (bib25) 1958; 70
Dimmock, Arora, Duffy, Reid, Allen, Kao (bib1) 1992; 8
Das, Das, Bandy, Stables, Dimmock (bib11) 2008; 16
Ahmad, Katiyar, Mukhtar (bib21) 2001
Singh, Khar (bib17) 2006
Dimmock, Elias, Beazely, Kandepu (bib9) 1999; 6
Youssef, El-Sherbeny (bib7) 2005; 338
Ferguson, Philpott (bib16) 2007
Dimmock, Padmanilayam, Puthucode, Nazarali, Motaganahalli, Zello, Quail, Oloo, Kraatz, Prisciak, Allen, Santos, Balzarini, De Clercq, Manavathu (bib3) 2001; 44
Odinets, Artyushin, Goryunov, Lyssenko, Rybalkina, Kosilkin, Timofeeva, Antipin (bib22) 2005; 16
Chuang, Cheng, Lin, Kuo (bib20) 2000; 38
References_xml – start-page: 459
  year: 2007
  ident: bib16
  publication-title: Curr. Cancer Drug Targets
  contributor:
    fullname: Philpott
– volume: 16
  start-page: 497
  year: 2005
  ident: bib22
  publication-title: Heteroatom Chem.
  contributor:
    fullname: Antipin
– volume: 6
  start-page: 1125
  year: 1999
  ident: bib9
  publication-title: Curr. Med. Chem.
  contributor:
    fullname: Kandepu
– volume: 337
  start-page: 42
  year: 2004
  ident: bib13
  publication-title: Arch. Pharm. Chem. Med. Chem.
  contributor:
    fullname: Awadalla
– volume: 121
  start-page: 1324
  year: 1999
  ident: bib34
  publication-title: J. Am. Chem. Soc.
  contributor:
    fullname: Grätzel
– year: 2000
  ident: bib29
  publication-title: Aminophosphonic and Aminophosphinic Acids
– volume: 8
  start-page: 291
  year: 1992
  ident: bib1
  publication-title: Drug Des. Discov.
  contributor:
    fullname: Kao
– volume: 42
  start-page: 5415
  year: 1999
  ident: bib14
  publication-title: J. Med. Chem.
  contributor:
    fullname: Morrissey
– volume: 6
  start-page: 129
  year: 2004
  ident: bib24
  publication-title: Cancer Cell
  contributor:
    fullname: Gottesman
– volume: 338
  start-page: 181
  year: 2005
  ident: bib7
  publication-title: Arch. Pharm. Chem. Life Sci.
  contributor:
    fullname: El-Sherbeny
– volume: 246
  start-page: 6599
  year: 1971
  end-page: 6605
  ident: bib26
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Stark
– volume: 42
  start-page: 71
  year: 2007
  ident: bib6
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Dimmock
– volume: 49
  start-page: 6129
  year: 2008
  ident: bib31
  publication-title: Tetrahedron Lett.
  contributor:
    fullname: Odinets
– volume: 43
  start-page: 1
  year: 2008
  ident: bib5
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Dimmock
– volume: 6
  start-page: 183
  year: 1990
  ident: bib10
  publication-title: Drug Des. Deliv.
  contributor:
    fullname: Lee
– volume: 163
  start-page: 3473
  year: 1999
  ident: bib18
  publication-title: J. Immunol.
  contributor:
    fullname: Sartor
– volume: 89
  start-page: 6447
  year: 1992
  end-page: 6451
  ident: bib27
  publication-title: PNAS
  contributor:
    fullname: Nishizuka
– volume: C59
  start-page: 605
  year: 2003
  ident: bib23
  publication-title: Acta Crystallogr.
  contributor:
    fullname: Antipin
– volume: 35
  start-page: 59
  year: 1986
  ident: bib32
  publication-title: J. Photochem.
  contributor:
    fullname: Steer
– volume: 70
  start-page: 539
  year: 1958
  ident: bib25
  publication-title: Angew Chem.
  contributor:
    fullname: Bourswaux
– volume: 338
  start-page: 175
  year: 2005
  ident: bib8
  publication-title: Arch. Pharm. Chem. Life Sci.
  contributor:
    fullname: El-Subbagh
– volume: 11
  start-page: 5461
  year: 2003
  ident: bib28
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Björkling
– volume: 44
  start-page: 586
  year: 2001
  ident: bib3
  publication-title: J. Med. Chem.
  contributor:
    fullname: Manavathu
– volume: 38
  start-page: 991
  year: 2000
  ident: bib20
  publication-title: Food Chem. Toxicol.
  contributor:
    fullname: Kuo
– volume: 38
  start-page: 169
  year: 2003
  ident: bib15
  publication-title: Eur. J. Med. Chem.
  contributor:
    fullname: Stables
– start-page: 259
  year: 2006
  ident: bib17
  publication-title: Anticancer Agents Med. Chem.
  contributor:
    fullname: Khar
– volume: 42
  start-page: 1358
  year: 1999
  ident: bib12
  publication-title: J. Med. Chem.
  contributor:
    fullname: Balzarini
– volume: 30
  start-page: 579
  year: 1977
  ident: bib33
  publication-title: Austr. J. Chem.
  contributor:
    fullname: Newland
– volume: 18
  start-page: 325
  year: 2003
  ident: bib4
  publication-title: J. Enzyme Inhib. Med. Chem.
  contributor:
    fullname: Stables
– volume: 12
  start-page: 19
  year: 1994
  ident: bib2
  publication-title: Drug Des. Discov.
  contributor:
    fullname: Kao
– start-page: 128
  year: 2001
  end-page: 139
  ident: bib21
  publication-title: Oxidants and Antioxidants in Cutaneous Biology
  contributor:
    fullname: Mukhtar
– volume: 45
  start-page: 729
  year: 2008
  ident: bib30
  publication-title: J. Heterocycl. Chem.
  contributor:
    fullname: Timofeeva
– volume: 16
  start-page: 3602
  year: 2008
  ident: bib11
  publication-title: Biorg. Med. Chem.
  contributor:
    fullname: Dimmock
– volume: 12
  start-page: 464
  year: 2001
  ident: bib19
  publication-title: Bioconjug. Chem.
  contributor:
    fullname: Misra
SSID ssj0005600
Score 2.1693091
Snippet A series of E, E- N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones 7a– k was prepared via the condensation of aromatic aldehydes with ω-aminophosphonates...
A series of E,E-N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones 7a-k was prepared via the condensation of aromatic aldehydes with omega-aminophosphonates...
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 2135
SubjectTerms Aminophosphonates
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Cell Line, Tumor
Drug Design
Drug Screening Assays, Antitumor
Humans
Inhibitory Concentration 50
N-phosphorylalkylene-3,5-bis(arylidene)piperid-4-ones
N-phosphorylalkylene-piperid-4-ones
Organophosphonates
Piperidones - chemistry
Piperidones - pharmacology
Structure-Activity Relationship
Structure–cytotoxicity–fluorescence relationship
Synthesis
Title Design, cytotoxic and fluorescent properties of novel N-phosphorylalkyl substituted E, E-3,5-bis(arylidene)piperid-4-ones
URI https://dx.doi.org/10.1016/j.ejmech.2008.10.019
https://www.ncbi.nlm.nih.gov/pubmed/19046794
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe67QFeEIyPjS_5AU2g1FWa2Gn8WLbAADFN6hjjqXJsV1sbmiptJ_Lfc46dptVAAyQemkaW69i5X8939t3PCL1KYRrSPUaJrzgzKTmUcMUlCSLWlZqrKKiSwo4HvZOL-CihSatVnxPalP1XSUMZyNpkzv6FtFeNQgHcg8zhClKH6x_J_agKyTBvTpaLfJH_cISso2yZF5a7yQRlzUw8tSWcnebXOvNOyOwyn8OnKDORTcrMm4NOsYEEyqtiJhMSwhcDZxqEHwuoaE4kNbROsytDmKwIJYb6_7er_c7ydfv5hpmkPm6uWRifiCK_Xgvo9847q02hMoWeXdkstmQiDM30VHjflqsKZtv_bQQOO4zyUrgkx_e6UOQ8zyZNIPIAhlnNPp-WxcL72tlY--BNpKFdkKuTcj6Do2HUa3-wpj7B8DFutl2u0Fa9g3NFwsDSVtf63_JPOpyzDWVumVScYWDI5X456dj1j3FHj79ru8EVd0zEoJsLNum8B6ZfplvGVGch622hnQCUJOjonf6H5OJjE6AU2QSqehx14mcVnXjzWbcYVmtW09l9dM-5O7hvcfoAtfR0F905rMW-iw5OLXd62cZnTSrgvI0P8GnDql4-RKUFdhuvYI0B1ngN1riBNc5HuII1vgFrvAZrnLQxgLpdQfr1CtBvNuH8CH15l5wdHhN3bgiRYeQvCFV-N2UijKI4Gmmf6ZjyWHWDVMoglFykItSMB5Qp6gvDcMhZzDWXXSqhVpiGj9H2FNrfQ5gacqtYRFJEmsqR4L5Oe0LpEY9jsOPYPiL1Sx_OLD3MsI6bHA-tkOxJr1AKQtpHvVoyQ2fiWtN1CGC65ZdPrCCb53AfrBxOn_5zm8_Q3eZf9RxtL4qlfoG25mr50oHxJ_pT1Ig
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design%2C+cytotoxic+and+fluorescent+properties+of+novel+N-phosphorylalkyl+substituted+E%2C+E-3%2C5-bis%28arylidene%29piperid-4-ones&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Makarov%2C+Michael+V.&rft.au=Rybalkina%2C+Ekaterina+Yu&rft.au=R%C3%B6schenthaler%2C+Gerd-Volker&rft.au=Short%2C+Kurt+W.&rft.date=2009-05-01&rft.pub=Elsevier+Masson+SAS&rft.issn=0223-5234&rft.eissn=1768-3254&rft.volume=44&rft.issue=5&rft.spage=2135&rft.epage=2144&rft_id=info:doi/10.1016%2Fj.ejmech.2008.10.019&rft.externalDocID=S0223523408005357
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon